Abstract:ABSTRACT Vectors derived from human immunodeficiency virus (HIV) are highly efficient vehicles for in vivo gene delivery. However, their biosafety is of major concern. Here we exploit the complexity of the HIV genome to provide lentivirus vectors with novel biosafety features. In addition to the structural genes, HIV contains two regulatory genes, tat and rev , that are essential for HIV replication, and four accessory genes that encode critical virulence factors. We previously reported that the HIV type 1 accessory open reading frames are dispensable for efficient gene transduction by a lentivirus vector. We now demonstrate that the requirement for the tat gene can be offset by placing constitutive promoters upstream of the vector transcript. Vectors generated from constructs containing such a chimeric long terminal repeat (LTR) transduced neurons in vivo at very high efficiency, whether or not they were produced in the presence of Tat. When the rev gene was also deleted from the packaging construct, expression of gag and pol was strictly dependent on Rev complementation in trans . By the combined use of a separate nonoverlapping Rev expression plasmid and a 5′ LTR chimeric transfer construct, we achieved optimal yields of vector of high transducing efficiency (up to 10 7 transducing units [TU]/ml and 10 4 TU/ng of p24). This third-generation lentivirus vector uses only a fractional set of HIV genes: gag , pol , and rev . Moreover, the HIV-derived constructs, and any recombinant between them, are contingent on upstream elements and trans complementation for expression and thus are nonfunctional outside of the vector producer cells. This split-genome, conditional packaging system is based on existing viral sequences and acts as a built-in device against the generation of productive recombinants. While the actual biosafety of the vector will ultimately be proven in vivo, the improved design presented here should facilitate testing of lentivirus vectors.

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery

A Third-Generation Lentivirus Vector with a Conditional Packaging System

Efficient gene transfer mediated by HIV-1-based defective lentivector and inhibition of HIV-1 replication

Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.

Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization

A Large U3 Deletion Causes Increased in Vivo Expression from a Nonintegrating Lentiviral Vector

[High-titer preparation of HIV-1-based defective lentivector and it mediated efficient gene transfer]

Notable Reduction in Illegitimate Integration Mediated by a PPT-deleted, Nonintegrating Lentiviral Vector.

RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy

A Single-Ltr HIV-1 Vector Optimized for Functional Genomics Applications

Transactivator and Structurally Optimized Inducible Lentiviral Vectors.

Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells

A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors

Lentiviral Delivery of Proteins for Genome Engineering

Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study

Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5

Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration

Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition

Lentivirus pre-packed with Cas9 protein for safer gene editing

Self-Repairing Herpesvirus Saimiri Deletion Variants